Can I read NCT02393248 Study Completion Insights on EtoBox?

NCT02393248 Study Completion Insights by KAISIYAABUDOUMIJITI is a document available to read on EtoBox.

What is NCT02393248 Study Completion Insights about?

This review discusses the role of FGFR inhibitors in the treatment of cholangiocarcinoma (CCA), a rare and aggressive cancer with limited treatment options. It highlights the significance of the FGF/FGFR signaling pathway in CCA pathophysiology and the potential of targeted therapies, particularly FGFR inhibitors, to improve patient outcomes. The document emphasizes the need for further research to address challenges such as therapy resistance and the effectiveness of these novel treatments.

Author

KAISIYAABUDOUMIJITI

Language

EN